Bax:Bcl2 Cancer Research Results
Bax:Bcl2, Bax:Bcl2 ratio: Click to Expand ⟱
| Source: |
| Type: |
Bax and Bcl-2 are the major members of Bcl-2 family that play a key role in tumor progression or inhibition of intrinsic apoptotic pathway triggered by mitochondrial dysfunction.
Bax/Bcl-2 ratio is typically significantly lower in tumors.
|
CRC, Colorectal Cancer: Click to Expand ⟱
Colorectal cancer is a broader term that encompasses both colon and rectal cancer.
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
CRC, |
T24/HTB-9 |
|
|
|
TumCG↓, TumCCA↑, MMP↓, Cyt‑c↑, Casp9↑, Casp3↑, p‑Akt↓, Bcl-2↓, BAX↑, Bax:Bcl2↑, 12LOX↓,
tumCV↓, selectivity↑, Casp3↑, Casp9↑, Bax:Bcl2↑, ATG5↑, Beclin-1↑, TumCP↓, MEK↓, ERK↓,
| - |
vitro+vivo, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
Nor, |
HUVECs |
|
|
|
angioG↓, VEGF↓, TumVol↓, Apoptosis↑, HSPD1 / HSP60↓, HTRA↓, survivin↓, XIAP↓, P21↑, *toxicity↓, *neuroP↑, *ROS↓, *COX2↓, *Inflam↓, *cardioP↑, AntiCan↑, ChemoSen↑, ROS↑, MMP↑, Bax:Bcl2↑, TumCG↓,
| - |
in-vitro, |
CRC, |
CT26 |
|
|
|
- |
in-vitro, |
CRC, |
HCT116 |
|
|
|
RadioS↑, TumCCA↑, γH2AX↑, DNAdam↑, p‑Akt↓, cycD1/CCND1↓, PPARγ↑, Bax:Bcl2↑, Casp3↑, Apoptosis↑,
| - |
vitro+vivo, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
CRC, |
SW480 |
|
|
|
- |
in-vitro, |
CRC, |
LoVo |
|
|
|
Dose↝, TumCP↓, selectivity↑, MMP↓, Apoptosis↑, TumCCA↑, NF-kB↓, CDK4↓, cycD1/CCND1↓, Casp9↑, Casp3↑, Bax:Bcl2↑, TumCG↓, ChemoSen↑, TNF-α↓, IL1β↓, P53↑, P21↑,
| - |
in-vitro, |
CRC, |
LS1034 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
tumCV↓, TumCCA↑, ROS↑, Ca+2↑, MMP↓, Apoptosis↑, Cyt‑c↑, Casp9↑, Bax:Bcl2↑,
TumCI↓, TumCMig↓, Apoptosis↑, p‑FAK↓, Src↓, MAPK↓, ERK↓, PI3K/Akt↓, Bax:Bcl2↑, Cyt‑c↑, MMP7↓,
| - |
in-vivo, |
CRC, |
Caco-2 |
|
|
|
- |
vitro+vivo, |
CRC, |
CX-1 |
|
|
|
Apoptosis↑, PI3K↓, Akt↓, P53↑, BAX↑, Bax:Bcl2↑, p‑PARP↑, TumCMig↓,
TumCP↓, Apoptosis↑, TumVol↓, Bax:Bcl2↑, EMT↓, TumCI↓, TumMeta↓, Wnt/(β-catenin)↓,
Showing Research Papers: 1 to 9 of 9
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 9
Pathway results for Effect on Cancer / Diseased Cells:
NA, unassigned ⓘ
HSPD1 / HSP60↓, 1, HTRA↓, 1,
Redox & Oxidative Stress ⓘ
ROS↑, 2,
Mitochondria & Bioenergetics ⓘ
MEK↓, 1, MMP↓, 3, MMP↑, 1, XIAP↓, 1,
Core Metabolism/Glycolysis ⓘ
12LOX↓, 1, PI3K/Akt↓, 1, PPARγ↑, 1,
Cell Death ⓘ
Akt↓, 1, p‑Akt↓, 2, Apoptosis↑, 7, BAX↑, 2, Bax:Bcl2↑, 9, Bcl-2↓, 1, Casp3↑, 4, Casp9↑, 4, Cyt‑c↑, 3, MAPK↓, 1, survivin↓, 1,
Transcription & Epigenetics ⓘ
tumCV↓, 2,
Autophagy & Lysosomes ⓘ
ATG5↑, 1, Beclin-1↑, 1,
DNA Damage & Repair ⓘ
DNAdam↑, 1, P53↑, 2, p‑PARP↑, 1, γH2AX↑, 1,
Cell Cycle & Senescence ⓘ
CDK4↓, 1, cycD1/CCND1↓, 2, P21↑, 2, TumCCA↑, 4,
Proliferation, Differentiation & Cell State ⓘ
EMT↓, 1, ERK↓, 2, PI3K↓, 1, Src↓, 1, TumCG↓, 3, Wnt/(β-catenin)↓, 1,
Migration ⓘ
Ca+2↑, 1, p‑FAK↓, 1, MMP7↓, 1, TumCI↓, 2, TumCMig↓, 2, TumCP↓, 3, TumMeta↓, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 1, VEGF↓, 1,
Immune & Inflammatory Signaling ⓘ
IL1β↓, 1, NF-kB↓, 1, TNF-α↓, 1,
Drug Metabolism & Resistance ⓘ
ChemoSen↑, 2, Dose↝, 1, RadioS↑, 1, selectivity↑, 2,
Functional Outcomes ⓘ
AntiCan↑, 1, TumVol↓, 2,
Total Targets: 56
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
ROS↓, 1,
Immune & Inflammatory Signaling ⓘ
COX2↓, 1, Inflam↓, 1,
Functional Outcomes ⓘ
cardioP↑, 1, neuroP↑, 1, toxicity↓, 1,
Total Targets: 6
Scientific Paper Hit Count for: Bax:Bcl2, Bax:Bcl2 ratio
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:6 Cells:% prod#:% Target#:352 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page